Mouse (71 sources):
abnormal adipose tissue physiology,
abnormal basal metabolism,
abnormal blood pressure regulation,
abnormal cell-mediated immunity,
abnormal chemokine level,
abnormal choriocapillaris morphology,
abnormal circulating lipid level,
abnormal fat pad morphology,
abnormal fatty acids level,
abnormal food intake,
abnormal food preference,
abnormal gluconeogenesis,
abnormal hormone level,
abnormal intestinal absorption,
abnormal intestinal lipid absorption,
abnormal kidney morphology,
abnormal lipid homeostasis,
abnormal lipid level,
abnormal macrophage chemotaxis,
abnormal macrophage physiology,
abnormal microglial cell physiology,
abnormal pericardium morphology,
abnormal peripheral nervous system regeneration,
abnormal plasma cell differentiation,
abnormal response to cardiac infarction,
abnormal response to infection,
abnormal retina photoreceptor morphology,
abnormal triglyceride level,
cardiac hypertrophy,
cardiovascular system phenotype,
decreased IgG1 level,
decreased IgG2a level,
decreased IgG2c level,
decreased adipocyte glucose uptake,
decreased body size,
decreased bone mass,
decreased brown adipose tissue amount,
decreased cardiac muscle glycogen level,
decreased circulating adiponectin level,
decreased circulating glucose level,
decreased fasting circulating glucose level,
decreased fatty acid oxidation,
decreased fatty acids level,
decreased interleukin-12 secretion,
decreased interleukin-6 secretion,
decreased intestinal cholesterol absorption,
decreased liver free fatty acids level,
decreased liver triglyceride level,
decreased muscle cell glucose uptake,
decreased percent body fat/body weight,
decreased skeletal muscle glycogen level,
decreased susceptibility to induced thrombosis,
decreased triglyceride level,
decreased tumor necrosis factor secretion,
disorganized photoreceptor outer segment,
disorganized retina outer nuclear layer,
endophthalmitis,
homeostasis/metabolism phenotype,
impaired adaptive thermogenesis,
impaired macrophage phagocytosis,
increased cardiac cell glucose uptake,
increased circulating VLDL triglyceride level,
increased circulating ketone body level,
increased fatty acids level,
increased intestinal glucose absorption,
increased liver triglyceride level,
increased sensitivity to induced morbidity/mortality,
increased susceptibility to bacterial infection induced morbidity/mortality,
increased transitional stage B cell number,
slow postnatal weight gain,
thin retina outer nuclear layer
[+]
|